Clinical trials
Scleroderma, Diffuse trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Completed | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanjay Gandhi Postgraduate Institute of Medical Sciences | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Cumberland Pharmaceuticals | 1 |
| Novartis Pharmaceuticals | 1 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Diffuse | 7 |
| Lung Diseases, Interstitial | 4 |
| Scleroderma, Systemic | 3 |
| Autoimmune Diseases | 2 |
| Connective Tissue Diseases | 2 |
| Arthritis, Rheumatoid | 1 |
| Fibrosis | 1 |
| Gangrene | 1 |
| Immune System Diseases | 1 |
| Pathologic Processes | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.